Expression, prognostic and predictive impact of VEGF and bFGF in non-small cell lung cancer

被引：67

作者：

Farhat, Fadi S. ^{[2
]}

Tfayli, Arafat ^{[3
]}

Fakhruddin, Najla ^{[5
]}

Mahfouz, Rami ^{[4
]}

Otrock, Zaher K. ^{[3
]}

Alameddine, Raafat S. ^{[3
,6
]}

Awada, Ahmad H. ^{[1
]}

Shamseddine, Ali ^{[3
,7
]}

机构：

[1] Univ Libre Bruxelles, Inst Jules Bordet, Med Oncol Clin, B-1000 Brussels, Belgium

[2] Hammoud Hosp Univ Med Ctr, Dept Hematol Oncol, Saida, Lebanon

[3] Amer Univ Beirut, Med Ctr, Dept Internal Med, Beirut, Lebanon

[4] Amer Univ Beirut, Med Ctr, Dept Pathol & Lab Med, Fac Med, Beirut, Lebanon

[5] Hammoud Hosp Univ Med Ctr, Dept Pathol, Saida, Lebanon

[6] Amer Univ Beirut, Nayef K Basil Canc Ctr, Beirut, Lebanon

[7] Amer Univ Beirut, Div Hematol Oncol, Beirut, Lebanon

来源：

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY | 2012年 / 84卷 / 02期

关键词：

Non-small cell lung cancer; VEGF; bFGF; Angiogenic markers; Expression; Prognostic impact; Review; ENDOTHELIAL GROWTH-FACTOR; VASCULAR-PERMEABILITY FACTOR; FACTOR MESSENGER-RNA; RANDOMIZED PHASE-II; INCREASED SERUM-LEVELS; TUMOR ANGIOGENESIS; FACTOR-C; CLINICAL-SIGNIFICANCE; LYMPHATIC VESSELS; FACTOR FAMILY;

D O I：

10.1016/j.critrevonc.2012.02.012

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Despite major advances in cancer therapeutics, the prognosis for lung cancer patients is still poor and the median survival for patients presenting with advanced non-small cell lung cancer (NSCLC) is only 8-10 months. Angiogenesis is an important biological process and a relatively early event during lung cancer pathogenesis. Anti-angiogenic agents are used in treating patients with NSCLC, and their molecular biomarkers are also being assessed to predict response. A better understanding of the biology of angiogenesis in NSCLC may reveal new targets for treating this malignancy. In this article, we review the expression and prognostic impact of the angiogenic growth factors, vascular endothelial growth factor and basic fibroblast growth factor, in NSCLC. (C) 2012 Published by Elsevier Ireland Ltd.

引用

页码：149 / 160

页数：12

共 119 条

[71] Vegfb gene knockout mice display reduced pathology and synovial angiogenesis in both antigen-induced and collagen-induced models of arthritis [J].

Mould, AW ;

Tonks, ID ;

Cahill, MM ;

Pettit, AR ;

Thomas, R ;

Hayward, NK ;

Kay, GF .

ARTHRITIS AND RHEUMATISM, 2003, 48 (09) :2660-2669

[72] Histopathologic and genetic alterations as predictors of response to treatment and survival in lung cancer: A review of published data [J].

Mountzios, Giannis ;

Dimopoulos, Meletios-Athanassios ;

Soria, Jean-Charles ;

Sanoudou, Despina ;

Papadimitriou, Christos A. .

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2010, 75 (02) :94-109

[73]

Nakashima T, 2004, MED SCI MONITOR, V10, pBR157

[74] The biology of vascular endothelial growth factor-B (VEGF-B) [J].

Nash, AD ;

Baca, M ;

Wright, C ;

Scotney, PD .

PULMONARY PHARMACOLOGY & THERAPEUTICS, 2006, 19 (01) :61-69

[75] Vandetanib Versus Gefitinib in Patients With Advanced Non-Small-Cell Lung Cancer: Results From a Two-Part, Double-Blind, Randomized Phase II Study [J].

Natale, Ronald B. ;

Bodkin, David ;

Govindan, Ramaswamy ;

Sleckman, Bethany G. ;

Rizvi, Naiyer A. ;

Capo, Adolfo ;

Germonpre, Paul ;

Eberhardt, Wilfried E. E. ;

Stockman, Paul K. ;

Kennedy, Sarah J. ;

Ranson, Malcolm .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15) :2523-2529

[76] Vascular endothelial growth factor (VEGF) and its receptors [J].

Neufeld, G ;

Cohen, T ;

Gengrinovitch, S ;

Poltorak, Z .

FASEB JOURNAL, 1999, 13 (01) :9-22

[77] ELEVATED LEVELS OF AN ANGIOGENIC PEPTIDE, BASIC FIBROBLAST GROWTH-FACTOR, IN THE URINE OF PATIENTS WITH A WIDE SPECTRUM OF CANCERS [J].

NGUYEN, M ;

WATANABE, H ;

BUDSON, AE ;

RICHIE, JP ;

HAYES, DF ;

FOLKMAN, J .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (05) :356-361

[78] Plasma Cytokine and Angiogenic Factor Profiling Identifies Markers Associated with Tumor Shrinkage in Early-Stage Non-Small Cell Lung Cancer Patients Treated with Pazopanib [J].

Nikolinakos, Petros G. ;

Altorki, Nasser ;

Yankelevitz, David ;

Tran, Hai T. ;

Yan, Shaoyu ;

Rajagopalan, Dilip ;

Bordogna, Walter ;

Ottesen, Lone H. ;

Heymach, John V. .

CANCER RESEARCH, 2010, 70 (06) :2171-2179

[79] Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small cell lung cancer [J].

O'Byrne, KJ ;

Koukourakis, MI ;

Giatromanolaki, A ;

Cox, G ;

Turley, H ;

Steward, WP ;

Gatter, K ;

Harris, AL .

BRITISH JOURNAL OF CANCER, 2000, 82 (08) :1427-1432

[80]

Ohta Y, 2007, J EXP CLIN CANC RES, V26, P301

← 3 4 5 6 7 8 9 10 11 12 →